Why Is Clover Wellness (CLOV) Stock Up Today? Director Chelsea Clinton purchased 100,000 shares of CLOV stockĀ 

Right now, investors of Clover Wellness (NASDAQ: CLOV) are grinning ear to ear. Although clov stock price stays down greater than 25% year-to-date (YTD), shares of the business are up over 20% today.

Why specifically is Clover Wellness trading greater right now?

Over the weekend break, it was reported that Clover supervisor Chelsea Clinton had actually lately bought shares of CLOV stock. The deal, which occurred on March 3, saw Clinton acquire 100,000 shares for a typical rate of $2.52 per share. In total amount, Clinton’s recent purchase totaled up to $252,530, according to a Form 4 submitted to the U.S. Securities and Exchange Compensation (SEC).

Why Is CLOV Stock Up Today?
Today, CLOV stock is up in reaction to Clinton’s purchase, which financiers are deeming a favorable signal. Oftentimes, director trading activity like this is very important to track since insiders frequently have a far better view of a company’s long-term growth possibility than retail financiers.

So, with that said in mind, are other experts of Clover bullish on the firm? In the past 12 months, insiders have purchased 2.2 million shares and also offered 22.9 million shares. That’s a web of 20.6 million shares offered. This mass insider selling seems to correlate with CLOV stock’s decline of more than 60% over the past one year.

Still, with Clinton’s current purchase, investors are questioning who else is wagering large on Clover Wellness. Let’s jump right in.

Who Else Is Betting Big on Clover Wellness?
Since the fourth quarter, 160 institutional capitalists very own shares of CLOV stock. That notes a quarter-0ver-quarter (QOQ) boost of 8.8%. During the duration, the overall quantity of shares held by institutional investors also increased from 105.7 million to 129.8 million, up nearly 23% QOQ. Allow’s take a look at the top five institutional shareholders.

Lead has 25.9 million shares or 7.65% possession. The firm purchased 8.8 million shares during Q4.
Greenoaks Capital Allies has 24.8 million shares or 7.34% possession. The company offered 24.8 million shares during Q4.
Baillie Gifford has 7.8 million shares or 2.3% possession. The firm bought 2.6 million shares during Q4.
Two Sigma Investments has 6.6 million shares or 1.95% possession. The firm purchased all 6.6 million shares throughout Q4.
PNC Financial Solutions (NYSE: PNC) has 6.4 million shares or 1.88% ownership. The firm marketed 249,850 shares throughout Q4.
Out of the leading 5 investors, 3 funds decreased their positions as well as two funds increased their settings. Greenoaks Resources Allies had one of the most noteworthy purchase, as the fund sold concerning 50% of its existing placement throughout Q4. 2 Sigma’s 6.6 million share acquisition was also significant, as the acquisition put it among the leading five shareholders.

You may also like